7 investors at OrbiMed Advisors, based in New York, NY with $15B under management.
Back to OrbiMed Advisors profile
Managing Partner, OrbiMed Advisors
Carter Neild is a Managing Partner at OrbiMed Advisors, a leading investment firm specializing in the healthcare and life sciences sectors. With a strategic focus on biotech, digital health, and artificial intelligence, Neild identifies and supports innovative companies poised to transform healthcare delivery and outcomes. His investment expertise spans early-stage ventures through established players seeking growth capital. Neild's track record includes notable investments that demonstrate his ability to recognize promising technologies and founding teams. Based at OrbiMed Advisors, he leverages deep industry knowledge and an extensive network to guide portfolio companies through critical growth phases. His work bridges cutting-edge science and practical healthcare applications, positioning him at the forefront of healthcare innovation investment.
General Partner, OrbiMed Advisors
David Bonita is a General Partner at OrbiMed Advisors, a leading investment firm specializing in healthcare innovation. With a focus on biotech, digital health, and artificial intelligence, Bonita identifies and partners with companies positioned to transform the healthcare landscape. His investment thesis centers on emerging technologies and business models that address critical gaps in patient care and clinical outcomes. At OrbiMed Advisors, he leverages his expertise to evaluate opportunities across the healthcare ecosystem, from early-stage biotech ventures to scaled digital health platforms. Bonita's track record includes notable investments that have contributed to the firm's reputation as a premier healthcare-focused venture capital investor. His strategic approach combines deep sector knowledge with a commitment to supporting founders building the next generation of healthcare solutions. Based on his LinkedIn profile, Bonita continues to actively source and evaluate investments
General Partner, OrbiMed Advisors
Geoffrey C. Hsu is a General Partner at OrbiMed Advisors, a leading investment firm focused on the healthcare and life sciences sectors. With expertise spanning biotech, digital health, and artificial intelligence, Hsu identifies and evaluates innovative companies positioned to transform healthcare delivery and outcomes. At OrbiMed Advisors, he leverages deep industry knowledge to support portfolio companies through capital deployment, strategic guidance, and operational expertise. His investment approach focuses on identifying promising founders and technologies at the intersection of biology and technology. Hsu's career reflects a commitment to advancing healthcare innovation through venture capital, with a track record of supporting transformative companies in highly competitive and rapidly evolving markets.
General Partner, OrbiMed Advisors
Matthew Rizzo is a General Partner at OrbiMed Advisors, a leading investment firm specializing in the healthcare and life sciences sectors. With a focus on biotech, digital health, and artificial intelligence, Rizzo identifies and supports innovative companies poised to transform healthcare delivery and outcomes. His investment portfolio includes notable ventures such as Carl L. Gordon, demonstrating his expertise in selecting high-impact opportunities within emerging healthcare technologies. At OrbiMed Advisors, Rizzo leverages deep industry knowledge and a robust network to mentor founders and drive value creation across portfolio companies. His strategic vision encompasses both traditional biotechnology innovations and cutting-edge digital health solutions, positioning him at the intersection of healthcare disruption and technological advancement.
General Partner, OrbiMed Advisors
Peter Thompson is a General Partner at OrbiMed Advisors, a leading investment firm focused on the healthcare and life sciences sectors. With expertise spanning biotech, digital health, and artificial intelligence, Thompson identifies and supports innovative companies poised to transform healthcare delivery and outcomes. Through his work at OrbiMed Advisors, he evaluates opportunities at the intersection of cutting-edge technology and healthcare innovation. Thompson's investment approach emphasizes identifying promising founders and breakthrough technologies with the potential to address significant unmet medical needs. His professional network includes relationships with notable entrepreneurs and industry leaders in the healthcare innovation space. Based on his role at OrbiMed Advisors, Thompson brings strategic insight and capital deployment experience to portfolio companies navigating the complex healthcare landscape.
General Partner, OrbiMed Advisors
Scotland Stevens is a General Partner at OrbiMed Advisors, a leading healthcare-focused investment firm. Based on his LinkedIn profile, Stevens brings specialized expertise to the firm's investment strategy across biotech, digital health, and artificial intelligence sectors. At OrbiMed Advisors, he identifies and evaluates promising opportunities in the healthcare innovation space, leveraging deep industry knowledge to support portfolio companies through growth and scaling phases. Stevens' investment acumen spans emerging therapeutic technologies and digital health solutions that address critical unmet medical needs. His track record includes notable investments that demonstrate his ability to recognize transformative healthcare ventures. Through his work at OrbiMed Advisors, Stevens contributes to the firm's mission of advancing healthcare innovation while generating strong returns for investors.
Managing Partner, OrbiMed Advisors
Sven H. Borho is a founding partner at OrbiMed who heads the firm's public equity team and serves as portfolio manager for flagship listed healthcare strategies, including the London-listed Worldwide Healthcare Trust, giving him an unusual role that spans both specialist healthcare investing and public trust management. He emphasizes a science-first investment philosophy where understanding underlying biology and clinical science takes priority over financial metrics, distinguishing his approach from more traditional public equity managers.
OrbiMed Advisors's investment team consists of 7 professionals, headquartered in New York, NY and managing $15B in assets. The team brings diverse backgrounds and specialized expertise to evaluate and support portfolio companies.
Across the team, OrbiMed Advisors's investors cover expertise in Biotech, Digital Health, AI. This breadth of sector knowledge enables the firm to evaluate opportunities across multiple verticals and provide specialized post-investment support to founders.
OrbiMed Advisors has 7 investors and partners on their team, based in New York, NY. Each team member brings specialized expertise across different sectors and investment stages.
OrbiMed Advisors's team consists of 7 investment professionals. View individual investor profiles above for detailed backgrounds, focus areas, and portfolio companies.
OrbiMed Advisors manages approximately $15B in assets under management with a team of 7 investment professionals, headquartered in New York, NY.
Newsletter
Join thousands of founders and investors. Every Tuesday.